ClinicalTrials.Veeva

Menu

The Effects of Sleep on Human Microbiota: Implications for Health and Disease

Mayo Clinic logo

Mayo Clinic

Status

Enrolling

Conditions

Sleep

Treatments

Behavioral: Sleep restriction
Dietary Supplement: Weight gain

Study type

Interventional

Funder types

Other

Identifiers

NCT02573753
15-002092

Details and patient eligibility

About

The aggregate of microorganisms inhabiting the human body can be regarded as a dynamic reflector of both healthy and disease states, altering in response to changes in the environment. This may precede clinically detectable disease; and thereby, could be used to predict disease onset and additionally monitor response to treatment and predict prognosis. The primary hypothesis of this pilot study is that the human microbial communities are influenced by sleep and altered in humans with abnormal sleep patterns, and they may ultimately relate to disease risk.

Enrollment

5,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Only subjects who are eligible for ongoing IRB-approved studies will be deemed eligible for this protocol.

Exclusion criteria

  • Pregnant or breast-feeding women
  • Subjects who are ineligible for ongoing IRB-approved studies will not be included in this protocol

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

5,000 participants in 3 patient groups

sleep restriction
Experimental group
Description:
Sleep restriction
Treatment:
Behavioral: Sleep restriction
normal sleep
No Intervention group
Description:
Normal sleep
weight gain
Experimental group
Description:
Weight gain
Treatment:
Dietary Supplement: Weight gain

Trial contacts and locations

1

Loading...

Central trial contact

Nick Wozniak; Laura Hammel

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems